ArticleMolecular imaging and biology2026
Photoacoustic Imaging of Muscle Tissue Oxygenation as a Noninvasive Biomarker in Mouse Models of Sickle Cell Disease.
Article in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo develop and validate photoacoustic imaging (PAI) as a method to assess hemoglobin counts and muscle tissue oxygen saturation in a mouse model of Sickle Cell Disease (SCD. PROCEDURES: In vivo PAI was performed on mice with a SCD phenotype and results were compared to those from animals carrying a homozygous knockout of Bisphosphoglycerate mutase (BPGM), meant to annul the SCD phenotype, as well as controls (129 strain), then further compared to sickling assay results of blood collected from the same mice.
resultsPAI of the hindlimb muscles of SCD mice demonstrated significant decrease in tissue oxygen saturation (sO2) compared to control mice (28.4% vs 35.5%). Further PAI of mice with a genetic knock out of BPGM on an SCD background revealed tissue sO2 significantly greater (32.6%) than SCD mice and close to those in controls. These results correlate well with standard measurements of RBC sickling via cell counts. Hemoglobin counts derived from PAI further confirm the reduced tissue oxygen saturation measurements in SCD mice.
conclusionsPAI synergizes the specificity of optical imaging with the depth penetration capability of ultrasound to measure tissue oxygen saturation at deeper levels of tissue. The results of this study suggest this imaging method can be used to non-invasively measure hemoglobin counts and tissue oxygen levels as in vivo biomarkers in preclinical models of SCD, and potentially in the clinic as well.
Indexed as
Identifiers
41811585What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.